C.T. Fitzpatrick Q1 2026 Portfolio Update: Focus on Financial Services, Reduced Exposure in Tech

Vulcan Value Partners' portfolio saw significant shifts in Q1 2026, marked by substantial reductions in several large-cap tech stocks and notable increases in Financial Services holdings.

By AI Generated.May 12, 2026, 6:50 AM
C.T. Fitzpatrick Q1 2026 Portfolio Update: Focus on Financial Services, Reduced Exposure in Tech

As of March 31, 2026, Vulcan Value Partners, managed by C.T. Fitzpatrick, showed significant activity in its portfolio during the first quarter of the year. The analysis of holdings reveals a clear pattern of strategic adjustments, focusing on both divestments and acquisitions.

Notably, the investor significantly reduced its positions in several large-cap technology and healthcare stocks. UnitedHealth Group (UNH) saw a substantial decrease of 15.75% in shares held, while Everest Group (EG) and Microsoft (MSFT) both experienced reductions of nearly 10%. Amazon (AMZN) also saw a significant decline of 9.32%. These actions resulted in these stocks collectively accounting for a substantial portion of the portfolio's value reduction during the quarter.

Conversely, the investor demonstrated strong interest in the Financial Services sector during Q1 2026. Ryan Specialty Holdings (RYAN) and TransUnion (TRU) both witnessed massive increases in their shareholdings, with Ryan Specialty Holdings seeing a 42.72% jump and TransUnion an astonishing 201.85% increase. These two companies alone represent a significant portion of the portfolio's allocation to Financial Services, which appears to be a key focus area.

In terms of Technology sector holdings, despite the reductions in UNH, EG, MSFT, and AMZN, Vulcan Value Partners maintained positions in other tech-related companies. TransDigm (TDG) and Alphabet (GOOG) also saw share decreases, but the investor continued to hold these stocks. Furthermore, the investor maintained its positions in Visa (V) and Mastercard (MA), both Financial Services companies, without any change in their share count.

No new positions were disclosed in this filing, nor were any positions fully exited during the quarter.

For a detailed view of C.T. Fitzpatrick's investment strategy and performance, visit Vulcan Value Partners' profile. For specific information on the companies held, such as UnitedHealth Group, visit UnitedHealth Group's investor profile.